site stats

Race oncology top 20 shareholders

WebNov 23, 2024 · Under the SPP, eligible existing shareholders on the Company's share register at 8.00pm (AEDT) on 22 November 2024 with a registered address in Australia or New Zealand (Eligible Shareholders) will be offered the opportunity to subscribe for up to A$30,000 worth of new fully paid ordinary shares in the Company (SPP Shares) at an offer … WebAug 20, 2024 · A half-million dollar investment in cancer fighter Race Oncology (ASX:RAC) from Australian biotech entrepreneur Dr Daniel Tillett has pushed shares in the company to a four-month high.. Race, which acquires abandoned cancer drugs to give them another shot at stardom, came out of a trading halt this morning to announce a $1.45m capital raise, …

Race Oncology (ASX:RAC) share price rises following preclinical …

WebOct 17, 2024 · Race Oncology's cash burn of AU$6.3m is about 1.7% of its AU$373m market capitalisation. So it could almost certainly just borrow a little to fund another year's growth, or else easily raise the ... WebUncover the latest insider trading activity for Race Oncology Limited (RAC). Know which insiders are buying and selling along with top shareholders and ownership breakdown. … charter fishing in hawaii https://hitechconnection.net

Race Oncology Ownership - Simply Wall St

Web2 days ago · Race Oncology Limited is an Australia-based precision oncology company. The Company is engaged in the research of the oncology drug, Zantrene and the … WebRace Oncology Ltd ABN 61 149 318 749 Registered office: L36, 1 Macquarie Place, Sydney NSW 2000 www.raceoncology.com . Top 20 Holders Race is please to share the current Top 20 shareholders as of 30 September 2024. Shareholders can expect regular updates in future quarterly reports. Position Holder Name Holding IC WebOct 21, 2024 · Read the latest Periodic Report General news from Race Oncology Limited (ASX:RAC) charter fishing in hilton head south carolina

Race Oncology ASX:RAC Stock Report - Simply Wall St

Category:About – Race Oncology

Tags:Race oncology top 20 shareholders

Race oncology top 20 shareholders

Management team – Race Oncology

WebRace Oncology is an Australian precision oncology company with a Phase 2/3 cancer drug called Zantrene (bisantrene dihydrochloride ... so the Substantial Shareholders list differs … WebHere you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology. ASX Announcements. Reports. Title Link; Annual Report 2024: Download: Race Oncology - Pitt Street Research Initiation Report - …

Race oncology top 20 shareholders

Did you know?

WebDr Tillett is the CEO and founder of Nucleics Pty Ltd, a private biotechnology company in the genomics space. He was previously a Senior Lecturer within the School of Pharmacy at La … WebA substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list. Shareholding changes less than 1% do not require notification to the market.

Webbusiness was sold to Morningstar) has operated independently from Aegis by former Aegis senior executives/shareholders to provide clients with unparalleled research that covers … WebFeb 5, 2024 · The Race Oncology Ltd share price rocketed 20.98% today, closing the day at $2.48 per share. Race Oncology Ltd (RAC) is an Australian pharmaceutical company with …

WebApr 7, 2024 · 8.4%. 10% most volatile stocks in AU Market. 14.9%. 10% least volatile stocks in AU Market. 3.5%. Stable Share Price: RAC is not significantly more volatile than the rest … WebMar 24, 2024 · Follow. The Company has compelling clinical data for Zantrene as a chemotherapeutic agent and is currently undertaking two Phase 1/2 clinical trials in Acute …

WebRace Oncology. Novel RNA-directed therapeutics to treat cancer & protect the heart. Learn More . About. Zantrene® is a potent small molecule inhibitor of the Fatso/Fat mass and …

WebMay 5, 2024 · The Race Oncology share price is moving higher today after the company reported it had raised $5.4 million from institutional and sophisticated investors in an oversubscribed placement. charter fishing in maineWebRank Top 20 Investors Number of Shares % Issued Capital; 1. HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED: 924,523,952: 30.84%: 2. J P MORGAN NOMINEES AUSTRALIA PTY LIMITED charter fishing in hilton head island scWebAug 20, 2024 · A half-million dollar investment in cancer fighter Race Oncology (ASX:RAC) from Australian biotech entrepreneur Dr Daniel Tillett has pushed shares in the company … charter fishing in manistee michiganWebRace Oncology is an ASX listed precision oncology company with a Phase II/III cancer drug called Zantrene. Home. About. Zantrene ® is a potent small molecule inhibitor of the … charter fishing in key west flWebNov 24, 2024 · For instance, total trading volume today is over 445% of the 4-week average for Race Oncology shares at 1,148,215. The Race Oncology share price is also down almost 6% in the past week of trading ... curriculum thw fachgruppe fkWebDescription. Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its … charter fishing in ludington miWebRace Oncology Targeting Zantrene® towards better cancer outcomes. Contact Us. Visit. L36, 1 Macquarie Place, Sydney, NSW, 2000. Email. [email protected]. Phone +61 2 … charter fishing in key west